Feb 26, 2026
Breaking Free from Opioid Addiction: How Ibogaine Treatment at MindScape Retreat Offers Real Hope
Opioid addiction has reached crisis proportions globally, with conventional treatments offering limited success rates an...
Read Article →Understanding Vivitrol
Vivitrol is the brand name for extended-release naltrexone — a monthly injection administered by a healthcare provider. Naltrexone is an opioid receptor antagonist: it binds to opioid receptors and blocks them, preventing any opioid (including heroin, fentanyl, or prescription painkillers) from producing euphoria. If you use opioids while on Vivitrol, you will not feel the effects. The injection lasts approximately 28-30 days.
Vivitrol is FDA-approved for the treatment of opioid use disorder and alcohol dependence. It does not cause physical dependence, does not produce euphoria, and cannot be diverted. The evidence base includes randomized controlled trials demonstrating reduced opioid use in patients who continue receiving monthly injections. However, Vivitrol does not address the underlying neurology of addiction — when patients stop receiving injections, relapse rates are high.
This is the fundamental distinction: Vivitrol manages addiction by blocking opioid effects. Ibogaine treats addiction by resetting the neurological systems that drive opioid seeking. Vivitrol requires lifelong monthly injections to maintain its effect. Ibogaine is typically a single treatment that creates lasting neurological change.
Note: Vivitrol is the injectable form of naltrexone. If you are looking for a comparison with oral naltrexone (daily pill form), see our comprehensive Ibogaine vs Naltrexone page, which covers both oral (ReVia/Depade) and injectable (Vivitrol) forms in detail.
Head-to-Head Comparison
| Ibogaine | Vivitrol (Naltrexone Injection) | |
|---|---|---|
| Mechanism | Neurological reset: opioid receptor restoration + GDNF upregulation + dopamine pathway reset + trauma processing | Opioid receptor blockade — prevents opioids from producing effects |
| Treatment Schedule | Single treatment session (1-2 days) with 90-day integration support | Monthly injection indefinitely — requires ongoing healthcare visits |
| Addresses Root Cause | Yes — resets the neurology that drives opioid seeking behavior | No — blocks opioid effects but does not change the underlying addiction neurology |
| Withdrawal Treatment | Eliminates acute withdrawal symptoms during the treatment session | Does not treat withdrawal — patients must be fully detoxed 7-14 days before first injection |
| Psychological Processing | Deep introspective processing of trauma and psychological drivers of addiction | No psychological component (requires separate counseling) |
| Craving Reduction | Reduces cravings by resetting dopamine and opioid receptor systems | Does not directly reduce cravings — blocks effects if relapse occurs |
| Duration of Effect | Sustained by noribogaine for months; neuroplastic changes may be permanent | 28-30 days per injection; effect ends when injection wears off |
| FDA Status | Not FDA-approved; legal in Mexico under medical supervision | FDA-approved since 2010 for opioid use disorder |
| Evidence Base | Observational studies, case reports, Stanford veteran study (Nature Medicine) | Randomized controlled trials, large-scale outcome data |
| Cost | Single treatment investment ($5,000-$12,000 depending on program length) | $1,000-$1,500 per injection monthly — $12,000-$18,000 per year ongoing |
Why Patients Switch
Many patients who come to MindScape have tried Vivitrol. The common experience: Vivitrol works while active — the monthly injection blocks opioid effects, which reduces use. But patients describe feeling like they are on a leash rather than free. The cravings persist (Vivitrol blocks effects, not desire), the underlying trauma remains unprocessed, and the knowledge that they are one missed injection away from relapse creates chronic anxiety.
When patients stop Vivitrol — whether by choice, due to side effects (injection site reactions, nausea, liver concerns), or due to logistical barriers to monthly healthcare visits — the relapse rate is high. This is because the underlying neurology of addiction was never addressed. The opioid receptors are still sensitized, the dopamine reward system is still hijacked, and the psychological pain driving the addiction is still present.
Ibogaine addresses what Vivitrol does not: the root neurology. Patients who have experienced both consistently describe ibogaine as fundamentally different — not a management tool but an actual treatment that changes their relationship to the substance at a neurological and psychological level.
Important Consideration
If you are currently receiving Vivitrol injections, you cannot take ibogaine immediately. Vivitrol blocks opioid receptors for approximately 28-30 days, and ibogaine acts partly through opioid receptors. Taking ibogaine while Vivitrol is active would reduce ibogaine's effectiveness and potentially create an unpredictable pharmacological interaction.
Our medical team requires a minimum waiting period after your last Vivitrol injection — typically 30-45 days, confirmed by clinical assessment. If you are considering ibogaine treatment, discuss the timing with your prescribing physician and our medical team well in advance so we can coordinate safely.
Common Questions
Not sure which approach is right for you? Take our eligibility assessment or speak with our clinical team.
100% Confidential · No Obligation · Response Within 24 Hours
100% Confidential · No Obligation · Available 7 Days a Week
Latest Research & News
Feb 26, 2026
Opioid addiction has reached crisis proportions globally, with conventional treatments offering limited success rates an...
Read Article →Feb 25, 2026
Ibogaine has been called a "miracle cure" for addiction by some, dismissed as dangerous pseudoscience by others, and stu...
Read Article →Feb 25, 2026
Opioid addiction has reached crisis levels across North America, with over 100,000 overdose deaths annually in the Unite...
Read Article →Feb 13, 2026
If you're reading this, you're probably in that exhausting, overwhelming place where you know something has to change — ...
Read Article →